Pivotal	O
role	O
for	O
the	O
NFIL3/E4BP4	B-protein
transcription	I-protein
factor	I-protein
in	O
interleukin	B-protein
3	I-protein
-mediated	O
survival	O
of	O
pro-B	B-cell_type
lymphocytes	I-cell_type
.	O

The	O
E2A-HLF	B-protein
(	I-protein
hepatic	I-protein
leukemia	I-protein
factor	I-protein
)	I-protein
oncoprotein	I-protein
,	O
generated	O
in	O
pro-B	B-cell_type
lymphocytes	I-cell_type
by	O
fusion	O
of	O
the	O
trans-activation	B-protein
domain	I-protein
of	O
E2A	B-protein
to	O
the	O
basic	B-protein
region/leucine	I-protein
zipper	I-protein
(	I-protein
bZIP	I-protein
)	I-protein
domain	I-protein
of	O
HLF	B-protein
,	O
functions	O
as	O
an	O
anti-apoptotic	B-protein
transcription	I-protein
factor	I-protein
in	O
leukemic	O
cell	O
transformation	O
.	O

When	O
introduced	O
into	O
interleukin	B-protein
3	I-protein
(	O
IL-3	B-protein
)	O
-dependent	O
mouse	O
pro-B	B-cell_type
lymphocytes	I-cell_type
,	O
E2A-HLF	B-protein
prevents	O
apoptosis	O
induced	O
by	O
growth	B-protein
factor	I-protein
deprivation	O
,	O
suggesting	O
that	O
IL-3	B-protein
mediates	O
cell	O
survival	O
through	O
activation	O
of	O
a	O
transcription	B-protein
factor	I-protein
whose	O
activity	O
can	O
be	O
constitutively	O
replaced	O
by	O
the	O
chimeric	B-protein
oncoprotein	I-protein
.	O

We	O
considered	O
four	O
bZIP	B-protein
transcription	I-protein
factors	I-protein
as	O
candidates	O
for	O
this	O
putative	O
IL-3-regulated	B-protein
factor	I-protein
,	O
each	O
of	O
which	O
binds	O
avidly	O
to	O
the	O
DNA	B-DNA
consensus	I-DNA
sequence	I-DNA
recognized	O
by	O
E2A-HLF	B-protein
and	O
is	O
related	O
to	O
the	O
Caenorhabditis	B-protein
elegans	I-protein
CES-2	I-protein
(	O
cell	B-protein
death	I-protein
specification	I-protein
protein	I-protein
)	O
neuron-specific	B-protein
mediator	I-protein
of	I-protein
cell	I-protein
death	I-protein
.	O

The	O
expression	O
and	O
binding	O
activity	O
of	O
the	O
Nfil3	B-protein
protein	I-protein
(	O
also	O
called	O
E4bp4	B-protein
)	O
,	O
but	O
not	O
of	O
Hlf	B-protein
,	O
Dbp	B-protein
,	O
or	O
Tef	B-protein
,	O
was	O
found	O
to	O
be	O
regulated	O
by	O
IL-3	B-protein
in	O
mouse	B-cell_line
pro-B	I-cell_line
cell	I-cell_line
lines	I-cell_line
(	O
Baf-3	B-cell_line
and	O
FL5.12	B-cell_line
)	O
.	O

Northern	O
blot	O
analysis	O
showed	O
that	O
Nfil3/E4bp4	B-protein
is	O
regulated	O
as	O
a	O
``	B-DNA
delayed-early	I-DNA
''	I-DNA
IL-3-responsive	I-DNA
gene	I-DNA
,	O
requiring	O
de	O
novo	O
protein	O
synthesis	O
.	O

In	O
the	O
absence	O
of	O
IL-3	B-protein
,	O
enforced	O
expression	O
of	O
the	O
human	B-DNA
NFIL3/E4BP4	I-DNA
cDNA	I-DNA
promoted	O
the	O
survival	O
but	O
not	O
the	O
growth	O
of	O
IL-3-dependent	B-cell_type
pro-B	I-cell_type
cells	I-cell_type
.	O

Our	O
results	O
implicate	O
NFIL3/E4BP4	B-protein
(	O
nuclear	B-protein
factor	I-protein
regulated	I-protein
by	I-protein
IL-3/adenovirus	I-protein
E4	I-protein
promoter	I-protein
binding	I-protein
protein	I-protein
)	O
in	O
a	O
distinct	O
growth	O
factor-regulated	O
signaling	O
pathway	O
that	O
is	O
responsible	O
for	O
the	O
survival	O
of	O
early	B-cell_type
B-cell	I-cell_type
progenitors	I-cell_type
,	O
and	O
whose	O
alteration	O
by	O
E2A-HLF	B-protein
leads	O
to	O
childhood	O
B	O
lineage	O
leukemia	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

94	NULL
,	NULL
pp	NULL
.	NULL

2609-2614	NULL
,	NULL
March	NULL
1997	NULL
Medical	NULL
Sciences	NULL
Pivotal	NULL
role	NULL
for	NULL
the	NULL
NFIL3/E4BP4	NULL
transcription	NULL
factor	NULL
in	NULL
interleukin	NULL
3-mediated	NULL
survival	NULL
of	NULL
pro-B	NULL
lymphocytes	NULL
(	NULL
apoptosis	NULL
/	NULL
hematopoietic	NULL
growth	NULL
factor	NULL
transduction	NULL
/leukemia	NULL
)	NULL
SatosHI	NULL
IKUusHima*	NULL
,	NULL
TAKESHI	NULL
INUKAI*	NULL
,	NULL
TosHIYA	NULL
INABAT	NULL
,	NULL
STEPHEN	NULL
D.	NULL
NmMERS	NULL
,	NULL
Jonn	NULL
L	NULL
.	NULL

CLevELaND§	NULL
!	NULL

,	NULL
AND	NULL
A.	NULL
THomas	NULL
LooxK*ll**	NULL
Departments	NULL
of	NULL
*Experimental	NULL
Oncology	NULL
and	NULL
$	NULL
Biochemistry	NULL
,	NULL
St.	NULL
Jude	NULL
Children	NULL
's	NULL
Research	NULL
Hospital	NULL
,	NULL
332	NULL
North	NULL
Lauderdale	NULL
,	NULL
Memphis	NULL
,	NULL
TN	NULL
38105	NULL
;	NULL
Departments	NULL
of	NULL
IPediatrics	NULL
and	NULL
``	NULL
Biochemistry	NULL
,	NULL
University	NULL
of	NULL
Tennessee	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
3	NULL
North	NULL
Dunlap	NULL
,	NULL
Memphis	NULL
,	NULL
TN	NULL
38163	NULL
;	NULL
*Department	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
Jichi	NULL
Medical	NULL
School	NULL
,	NULL
3311-1	NULL
Yakushiji	NULL
,	NULL
Minamikawachi-machi	NULL
,	NULL
Tochigi	NULL
329-04	NULL
,	NULL
Japan	NULL
;	NULL
and	NULL
#	NULL
Memorial	NULL
Sloan-Kettering	NULL
Cancer	NULL
Center	NULL
,	NULL
1275	NULL
York	NULL
Avenue	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10021	NULL
Communicated	NULL
by	NULL
Charles	NULL
Sherr	NULL
,	NULL
St.	NULL
Jude	NULL
Children	NULL
's	NULL
Research	NULL
Hospital	NULL
,	NULL
Memphis	NULL
,	NULL
TN	NULL
,	NULL
December	NULL
27	NULL
,	NULL
1996	NULL
(	NULL
received	NULL
for	NULL
review	NULL
November	NULL
25	NULL
,	NULL
1996	NULL
)	NULL
ABSTRACT	NULL
The	NULL
E2A-HLF	NULL
(	NULL
hepatic	NULL
leukemia	NULL
factor	NULL
)	NULL
oncoprotein	NULL
,	NULL
generated	NULL
in	NULL
pro-B	NULL
lymphocytes	NULL
by	NULL
fusion	NULL
of	NULL
the	NULL
trans-activation	NULL
domain	NULL
of	NULL
E24	NULL
to	NULL
the	NULL
basic	NULL
region/	NULL
leucine	NULL
zipper	NULL
(	NULL
bZIP	NULL
)	NULL
domain	NULL
of	NULL
HLF	NULL
,	NULL
functions	NULL
as	NULL
an	NULL
anti-apoptotic	NULL
transcription	NULL
factor	NULL
in	NULL
leukemic	NULL
cell	NULL
trans-formation	NULL
.	NULL

When	NULL
introduced	NULL
into	NULL
interleukin	NULL
3	NULL
(	NULL
IL-3	NULL
)	NULL
-dependent	NULL
mouse	NULL
pro-B	NULL
lymphocytes	NULL
,	NULL
E2A-HLF	NULL
prevents	NULL
apoptosis	NULL
induced	NULL
by	NULL
growth	NULL
factor	NULL
deprivation	NULL
,	NULL
suggesting	NULL
that	NULL
IL-3	NULL
mediates	NULL
cell	NULL
survival	NULL
through	NULL
activation	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
whose	NULL
activity	NULL
can	NULL
be	NULL
constitutively	NULL
replaced	NULL
by	NULL
the	NULL
chimeric	NULL
oncoprotein	NULL
.	NULL

We	NULL
considered	NULL
four	NULL
bZIP	NULL
transcription	NULL
factors	NULL
as	NULL
candidates	NULL
for	NULL
this	NULL
putative	NULL
IL-3-regulated	NULL
factor	NULL
,	NULL
each	NULL
of	NULL
which	NULL
binds	NULL
avidly	NULL
to	NULL
the	NULL
DNA	NULL
consensus	NULL
sequence	NULL
recognized	NULL
by	NULL
E2A-HLF	NULL
and	NULL
is	NULL
related	NULL
to	NULL
the	NULL
Caenorhabditis	NULL
elegans	NULL
CES-2	NULL
(	NULL
cell	NULL
death	NULL
specification	NULL
protein	NULL
)	NULL
neuron-specific	NULL
mediator	NULL
of	NULL
cell	NULL
death	NULL
.	NULL

The	NULL
expression	NULL
and	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
Nfil3	NULL
protein	NULL
(	NULL
also	NULL
called	NULL
E4bp4	NULL
)	NULL
,	NULL
but	NULL
not	NULL
of	NULL
HIf	NULL
,	NULL
Dbp	NULL
,	NULL
or	NULL
Tef	NULL
,	NULL
was	NULL
found	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
IL-3	NULL
in	NULL
mouse	NULL
pro-B	NULL
cell	NULL
lines	NULL
(	NULL
Baf-3	NULL
and	NULL
FL5S.12	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
showed	NULL
that	NULL
Nf	NULL
#	NULL
/3/£E4bp4	NULL
is	NULL
regulated	NULL
as	NULL
a	NULL
``	NULL
delayed-early	NULL
``	NULL
IL-3-responsive	NULL
gene	NULL
,	NULL
requiring	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
IL-3	NULL
,	NULL
enforced	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
NFIL3/E4BP4	NULL
cDNA	NULL
promoted	NULL
the	NULL
survival	NULL
but	NULL
not	NULL
the	NULL
growth	NULL
of	NULL
IL-3-dependent	NULL
pro-B	NULL
cells	NULL
.	NULL

Our	NULL
results	NULL
implicate	NULL
NFIL3/E4BP4	NULL
(	NULL
nuclear	NULL
factor	NULL
regulated	NULL
by	NULL
IL-3/adenovirus	NULL
E4	NULL
promoter	NULL
binding	NULL
protein	NULL
)	NULL
in	NULL
a	NULL
distinct	NULL
growth	NULL
factor-regulated	NULL
signaling	NULL
pathway	NULL
that	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
survival	NULL
of	NULL
early	NULL
B-cell	NULL
progenitors	NULL
,	NULL
and	NULL
whose	NULL
alteration	NULL
by	NULL
E2A-HLF	NULL
leads	NULL
to	NULL
childhood	NULL
B	NULL
lineage	NULL
leukemia	NULL
.	NULL

The	NULL
elimination	NULL
of	NULL
defective	NULL
T	NULL
and	NULL
B	NULL
lymphocyte	NULL
progenitors	NULL
by	NULL
apoptosis	NULL
has	NULL
important	NULL
implications	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
normal	NULL
development	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
and	NULL
for	NULL
malignant	NULL
transformation	NULL
in	NULL
the	NULL
leukemias	NULL
and	NULL
lymphomas	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

This	NULL
process	NULL
is	NULL
greatly	NULL
influenced	NULL
by	NULL
cytokines	NULL
that	NULL
act	NULL
on	NULL
lymphoid	NULL
and	NULL
hematopoietic	NULL
precursors	NULL
,	NULL
including	NULL
interleukin	NULL
3	NULL
(	NULL
IL-3	NULL
)	NULL
,	NULL
which	NULL
supports	NULL
the	NULL
in	NULL
vitro	NULL
proliferation	NULL
of	NULL
multipotent	NULL
stem	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
many	NULL
progenitor	NULL
cells	NULL
already	NULL
committed	NULL
to	NULL
particular	NULL
lineages	NULL
(	NULL
4	NULL
)	NULL
.	NULL

When	NULL
IL-3-dependent	NULL
cell	NULL
lines	NULL
are	NULL
deprived	NULL
of	NULL
growth	NULL
factor	NULL
,	NULL
they	NULL
not	NULL
only	NULL
stop	NULL
proliferating	NULL
but	NULL
undergo	NULL
apoptosis	NULL
as	NULL
well	NULL
,	NULL
indicating	NULL
that	NULL
IL-3	NULL
promotes	NULL
cell	NULL
survival	NULL
by	NULL
suppression	NULL
of	NULL
programmed	NULL
cell	NULL
death	NULL
(	NULL
5-7	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
identify	NULL
the	NULL
key	NULL
molecules	NULL
through	NULL
which	NULL
IL-3-generated	NULL
survival	NULL
signals	NULL
are	NULL
transduced	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

Copyright	NULL
©	NULL
1997	NULL
by	NULL
Tar	NULL
Narronat	NULL
Acapemy	NULL
or	NULL
Sciences	NULL
or	NULL
THE	NULL
USA	NULL
0027-8424	NULL
/97/942609-6	NULL
$	NULL
2.00	NULL
/0	NULL
PNAS	NULL
is	NULL
available	NULL
online	NULL
at	NULL
http	NULL
:	NULL
//www.pnas.org	NULL
.	NULL

2609	NULL
The	NULL
EZA-HLF	NULL
(	NULL
hepatic	NULL
leukemia	NULL
factor	NULL
)	NULL
fusion	NULL
protein	NULL
,	NULL
which	NULL
drives	NULL
the	NULL
leukemic	NULL
conversion	NULL
of	NULL
pro-B	NULL
lymphocytes	NULL
harboring	NULL
a	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
chromosomal	NULL
translocation	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
,	NULL
can	NULL
block	NULL
apoptosis	NULL
caused	NULL
by	NULL
IL-3	NULL
deprivation	NULL
(	NULL
10	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
its	NULL
primary	NULL
effect	NULL
is	NULL
on	NULL
cell	NULL
survival	NULL
rather	NULL
than	NULL
cell	NULL
growth	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
close	NULL
homology	NULL
between	NULL
the	NULL
basic	NULL
region/	NULL
leucine	NULL
zipper	NULL
(	NULL
bZIP	NULL
)	NULL
DNA	NULL
binding	NULL
and	NULL
dimerization	NULL
domain	NULL
of	NULL
HLF	NULL
and	NULL
that	NULL
of	NULL
CES-2	NULL
,	NULL
a	NULL
neuron-specific	NULL
cell-death	NULL
specification	NULL
protein	NULL
in	NULL
the	NULL
nematode	NULL
Caenorhabditis	NULL
elegans	NULL
,	NULL
we	NULL
postulated	NULL
that	NULL
E2A-HLF	NULL
interferes	NULL
with	NULL
an	NULL
evolutionarily	NULL
conserved	NULL
pathway	NULL
that	NULL
can	NULL
have	NULL
both	NULL
positive	NULL
and	NULL
negative	NULL
effects	NULL
on	NULL
the	NULL
survival	NULL
of	NULL
B-lymphocyte	NULL
progenitors	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

To	NULL
explain	NULL
the	NULL
ability	NULL
of	NULL
E2A-HLF	NULL
to	NULL
block	NULL
apoptosis	NULL
resulting	NULL
from	NULL
IL-3	NULL
deprivation	NULL
,	NULL
we	NULL
reasoned	NULL
that	NULL
it	NULL
might	NULL
constitutively	NULL
replace	NULL
the	NULL
function	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
whose	NULL
activation	NULL
is	NULL
a	NULL
normal	NULL
event	NULL
within	NULL
the	NULL
signaling	NULL
pathway	NULL
regulated	NULL
by	NULL
IL-3	NULL
.	NULL

As	NULL
initial	NULL
candidates	NULL
for	NULL
this	NULL
regulatory	NULL
role	NULL
,	NULL
we	NULL
selected	NULL
mammalian	NULL
bZIP	NULL
transcription	NULL
factors	NULL
that	NULL
are	NULL
highly	NULL
related	NULL
to	NULL
the	NULL
C.	NULL
elegans	NULL
CES-2	NULL
protein	NULL
and	NULL
that	NULL
bind	NULL
avidly	NULL
to	NULL
the	NULL
same	NULL
DNA	NULL
binding	NULL
sequence	NULL
.	NULL

These	NULL
include	NULL
members	NULL
of	NULL
the	NULL
mammalian	NULL
proline-	NULL
and	NULL
acidic	NULL
amino	NULL
acid-rich	NULL
(	NULL
PAR	NULL
)	NULL
subfamily	NULL
of	NULL
bZIP	NULL
proteins	NULL
:	NULL
HLF	NULL
(	NULL
8	NULL
,	NULL
9	NULL
,	NULL
12-14	NULL
)	NULL
,	NULL
DBP	NULL
(	NULL
albumin	NULL
gene	NULL
promoter	NULL
D-box	NULL
binding	NULL
protein	NULL
)	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
,	NULL
and	NULL
TEF	NULL
(	NULL
thyrotroph	NULL
embryonic	NULL
factor	NULL
)	NULL
(	NULL
17	NULL
)	NULL
.	NULL

We	NULL
also	NULL
analyzed	NULL
a	NULL
related	NULL
bZIP	NULL
protein	NULL
called	NULL
E4BP4	NULL
,	NULL
isolated	NULL
by	NULL
its	NULL
ability	NULL
to	NULL
recognize	NULL
the	NULL
proximal	NULL
activating	NULL
transcription	NULL
factor	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
adenovirus	NULL
E4	NULL
promoter	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
,	NULL
and	NULL
later	NULL
independently	NULL
identified	NULL
as	NULL
NFIL3	NULL
,	NULL
a	NULL
protein	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
a	NULL
similar	NULL
sequence	NULL
motif	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-3	NULL
promoter	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
report	NULL
that	NULL
murine	NULL
Nfil3/EA4bp4	NULL
is	NULL
regulated	NULL
by	NULL
IL-3	NULL
and	NULL
that	NULL
enforced	NULL
expression	NULL
of	NULL
its	NULL
human	NULL
counterpart	NULL
in	NULL
IL-3-deprived	NULL
cells	NULL
prevents	NULL
apoptosis	NULL
.	NULL

Thus	NULL
,	NULL
this	NULL
transcription	NULL
factor	NULL
normally	NULL
regulates	NULL
a	NULL
pivotal	NULL
step	NULL
in	NULL
a	NULL
growth-factor	NULL
responsive	NULL
anti-apoptotic	NULL
signaling	NULL
pathway	NULL
whose	NULL
alteration	NULL
likely	NULL
contributes	NULL
to	NULL
human	NULL
B-lineage	NULL
leukemia	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Culture	NULL
.	NULL

Baf-3	NULL
and	NULL
FL5.12	NULL
pro-B	NULL
lymphocytes	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
Abbreviations	NULL
:	NULL
IL-3	NULL
,	NULL
interleukin	NULL
3	NULL
;	NULL
bZIP	NULL
,	NULL
basic	NULL
region	NULL
/leucine	NULL
zipper	NULL
;	NULL
PAR	NULL
,	NULL
proline-	NULL
and	NULL
acidic	NULL
amino	NULL
acid-rich	NULL
;	NULL
NFIL3	NULL
,	NULL
nuclear	NULL
factor	NULL
regulated	NULL
by	NULL
IL-3	NULL
;	NULL
E4BP4	NULL
,	NULL
adenovirus	NULL
E4	NULL
promoter	NULL
binding	NULL
protein	NULL
;	NULL
HLF	NULL
,	NULL
hepatic	NULL
leukemia	NULL
factor	NULL
;	NULL
DBP	NULL
,	NULL
albumin	NULL
gene	NULL
promoter	NULL
D-box	NULL
binding	NULL
protein	NULL
;	NULL
TEF	NULL
,	NULL
thyrotroph	NULL
embryonic	NULL
factor	NULL
;	NULL
CES-2	NULL
,	NULL
cell	NULL
death	NULL
specification	NULL
protein	NULL
of	NULL
Caenorhabditis	NULL
elegans	NULL
;	NULL
GAPDH	NULL
,	NULL
glyceralde-hyde-3-phosphate	NULL
dehydrogenase	NULL
.	NULL

Data	NULL
deposition	NULL
:	NULL
The	NULL
sequence	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
has	NULL
been	NULL
deposited	NULL
in	NULL
the	NULL
GenBank	NULL
database	NULL
(	NULL
accession	NULL
no	NULL
.	NULL

U83148	NULL
)	NULL
.	NULL

**To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
at	NULL
:	NULL
Department	NULL
of	NULL
Experimental	NULL
Oncology	NULL
,	NULL
St.	NULL
Jude	NULL
Children	NULL
's	NULL
Research	NULL
Hospital	NULL
,	NULL
332	NULL
North	NULL
Lauderdale	NULL
,	NULL
Memphis	NULL
,	NULL
TN	NULL
38105.	NULL
e-mail	NULL
:	NULL
thomas.Jook	NULL
@	NULL
stjude.org	NULL
.	NULL

2610	NULL
Medical	NULL
Sciences	NULL
:	NULL
Ikushima	NULL
et	NULL
al	NULL
.	NULL

serum	NULL
,	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
55	NULL
wM	NULL
2-mercaptoethanol	NULL
,	NULL
and	NULL
10	NULL
%	NULL
WEHI-3B	NULL
conditioned	NULL
medium	NULL
as	NULL
a	NULL
source	NULL
of	NULL
IL-3	NULL
.	NULL

In	NULL
restimulation	NULL
experiments	NULL
,	NULL
recombinant	NULL
mouse	NULL
IL-3	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
)	NULL
was	NULL
added	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10	NULL
ng/ml	NULL
.	NULL

Transfectants	NULL
were	NULL
generated	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
by	NULL
electroporation	NULL
using	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
and	NULL
80	NULL
ug	NULL
of	NULL
pMT-CB6+	NULL
/	NULL
NFIL3/E4BPA	NULL
vector	NULL
,	NULL
with	NULL
the	NULL
Gene	NULL
Pulser	NULL
(	NULL
Bio-Rad	NULL
)	NULL
set	NULL
at	NULL
300	NULL
V	NULL
and	NULL
960	NULL
uF	NULL
.	NULL

Cells	NULL
were	NULL
separated	NULL
into	NULL
24	NULL
pools	NULL
A	NULL
Preimmune	NULL
Anti-E4BP4	NULL
i	NULL
IL-3	NULL
4L-3	NULL
|	NULL
L-3	NULL
hro	NULL
0	NULL
20	NULL
4	NULL
B8	NULL
420	NULL
00	NULL
20	NULL
40	NULL
80	NULL
120	NULL
0	NULL
8	NULL
420	NULL
»	NULL
#	NULL
#	NULL
s	NULL
Bat-3	NULL
cells	NULL
t	NULL
W	NULL
w	NULL
=	NULL
m	NULL
[	NULL
R	NULL
n	NULL
n	NULL
nn	NULL
W	NULL
is	NULL
we	NULL
we	NULL
<	NULL
®	NULL
wt	NULL
5	NULL
(	NULL
t	NULL
w	NULL
0	NULL
[	NULL
‘	NULL
uhuh	NULL
.	NULL

is	NULL
1	NULL
20	NULL
3	NULL
40	NULL
§	NULL
0	NULL
60	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11°	NULL
12	NULL
13	NULL
Baf-3	NULL
cells	NULL
p	NULL
-	NULL
t-	NULL
wit	NULL
WZ	NULL
]	NULL
E4BP4	NULL
46	NULL
-	NULL
--	NULL
-s	NULL
FL5.12	NULL
cells	NULL
6	NULL
-	NULL
a-*+	NULL
@	NULL
t	NULL
#	NULL
#	NULL
]	NULL
E4BP4	NULL
46_-—.———	NULL
--	NULL
—-	NULL
1°	NULL
__	NULL
2	NULL
3	NULL
4	NULL
5	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
immediately	NULL
after	NULL
electroporation	NULL
and	NULL
selected	NULL
by	NULL
incubating	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
G418	NULL
(	NULL
0.6	NULL
mg/ml	NULL
)	NULL
for	NULL
2	NULL
weeks	NULL
.	NULL

Nine	NULL
independent	NULL
pools	NULL
of	NULL
transfected	NULL
cells	NULL
were	NULL
selected	NULL
for	NULL
further	NULL
analysis	NULL
,	NULL
and	NULL
four	NULL
clones	NULL
were	NULL
obtained	NULL
from	NULL
one	NULL
of	NULL
these	NULL
pools	NULL
by	NULL
limiting	NULL
dilution	NULL
.	NULL

NFIL3/E4BP4	NULL
expression	NULL
was	NULL
induced	NULL
by	NULL
treating	NULL
cells	NULL
from	NULL
each	NULL
of	NULL
the	NULL
nine	NULL
pools	NULL
,	NULL
and	NULL
the	NULL
four	NULL
clones	NULL
were	NULL
derived	NULL
by	NULL
limiting	NULL
dilution	NULL
with	NULL
100	NULL
uM	NULL
ZnSO	NULL
,	NULL
for	NULL
24	NULL
hr	NULL
prior	NULL
to	NULL
growth	NULL
factor	NULL
deprivation	NULL
.	NULL

Viable	NULL
B	NULL
Preimmune	NULL
Anti-E4BP4	NULL
+IL8	NULL
___	NULL
+	NULL
1L-3	NULL
'	NULL
+1L-3	NULL
hro	NULL
0	NULL
05	NULL
40	NULL
20	NULL
s	NULL
0	NULL
os	NULL
1	NULL
2030	NULL
0	NULL
0s	NULL
Baf-3	NULL
M	NULL
cells	NULL
-	NULL
ms	NULL
tnt	NULL
OB	NULL
.	NULL

<	NULL
4	NULL
wa	NULL
wt	NULL
<	NULL
[	NULL
is	NULL
FL6.12	NULL
cells	NULL
ws	NULL
.	NULL

With	NULL
..	NULL
<	NULL
4	NULL
C	NULL
|	NULL
|A	NULL
.	NULL

AAAS	NULL
15	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Nfil3/E4bp4	NULL
binding	NULL
activity	NULL
is	NULL
regulated	NULL
by	NULL
IL-3	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
IL-3-dependent	NULL
mouse	NULL
pro-B	NULL
cells	NULL
(	NULL
Baf-3	NULL
or	NULL
FLS5.12	NULL
)	NULL
were	NULL
studied	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
with	NULL
a	NULL
P-labeled	NULL
oligonucleotide	NULL
probe	NULL
containing	NULL
the	NULL
HLF	NULL
consensus	NULL
binding	NULL
sequence	NULL
(	NULL
GTTACGTAAC	NULL
;	NULL
lanes	NULL
1-10	NULL
)	NULL
.	NULL

Lanes	NULL
2-5	NULL
and	NULL
7-10	NULL
show	NULL
results	NULL
at	NULL
the	NULL
indicated	NULL
intervals	NULL
after	NULL
withdrawal	NULL
of	NULL
IL-3	NULL
from	NULL
the	NULL
medium	NULL
;	NULL
lanes	NULL
1	NULL
and	NULL
6	NULL
depict	NULL
findings	NULL
for	NULL
stable	NULL
culture	NULL
in	NULL
IL-3	NULL
.	NULL

Brackets	NULL
indicate	NULL
Nfil3/EA4bp4-DNA	NULL
complexes	NULL
(	NULL
lanes	NULL
1-5	NULL
)	NULL
,	NULL
and	NULL
solid	NULL
arrowheads	NULL
indicate	NULL
the	NULL
supershifted	NULL
complex	NULL
that	NULL
was	NULL
evident	NULL
after	NULL
incubation	NULL
with	NULL
antiserum	NULL
specific	NULL
for	NULL
Nfil3/EA4bpd4	NULL
(	NULL
lanes	NULL
6-10	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
for	NULL
extract	NULL
integrity	NULL
,	NULL
the	NULL
mobility	NULL
shift	NULL
assay	NULL
was	NULL
also	NULL
performed	NULL
with	NULL
an	NULL
SP1	NULL
transcription	NULL
factor	NULL
consensus	NULL
sequence	NULL
probe	NULL
on	NULL
extracts	NULL
from	NULL
cells	NULL
growing	NULL
in	NULL
IL-3	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
and	NULL
after	NULL
its	NULL
withdrawal	NULL
(	NULL
lanes	NULL
12	NULL
and	NULL
13	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Same	NULL
as	NULL
in	NULL
4	NULL
,	NULL
except	NULL
that	NULL
extracts	NULL
were	NULL
analyzed	NULL
from	NULL
cells	NULL
deprived	NULL
of	NULL
ligand	NULL
for	NULL
8	NULL
hr	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
6	NULL
,	NULL
and	NULL
11	NULL
)	NULL
and	NULL
after	NULL
the	NULL
indicated	NULL
intervals	NULL
following	NULL
IL-3	NULL
addition	NULL
(	NULL
lanes	NULL
2-5	NULL
,	NULL
7-10	NULL
,	NULL
and	NULL
12	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
showing	NULL
levels	NULL
of	NULL
the	NULL
~56-	NULL
to	NULL
58-kDa	NULL
Nfil3/E4bp4	NULL
protein	NULL
in	NULL
Baf-3	NULL
and	NULL
FL5.12	NULL
cells	NULL
deprived	NULL
of	NULL
IL-3	NULL
for	NULL
8	NULL
hr	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
at	NULL
1-hr	NULL
intervals	NULL
following	NULL
reinstatement	NULL
of	NULL
the	NULL
cytokines	NULL
.	NULL

Nfil3/EA4bp4	NULL
protein	NULL
levels	NULL
were	NULL
4.1-	NULL
and	NULL
4.5-fold	NULL
higher	NULL
,	NULL
respectively	NULL
,	NULL
in	NULL
Baf-3	NULL
and	NULL
FLS5.12	NULL
cells	NULL
,	NULL
4	NULL
hr	NULL
after	NULL
IL-3	NULL
restimulation	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
than	NULL
in	NULL
cells	NULL
deprived	NULL
of	NULL
IL-3	NULL
for	NULL
8	NULL
hr	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Nfil3/EA4bp4	NULL
levels	NULL
in	NULL
cells	NULL
growing	NULL
continuously	NULL
in	NULL
IL-3	NULL
were	NULL
2.5-	NULL
(	NULL
Baf-3	NULL
cells	NULL
)	NULL
and	NULL
1.8-fold	NULL
(	NULL
FL5.12	NULL
cells	NULL
)	NULL
higher	NULL
than	NULL
in	NULL
IL-3-deprived	NULL
cells	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Medical	NULL
Sciences	NULL
:	NULL
Ikushima	NULL
et	NULL
al	NULL
.	NULL

cell	NULL
counts	NULL
were	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
dye	NULL
exclusion	NULL
in	NULL
triplicate	NULL
assays	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
.	NULL

Extraction	NULL
of	NULL
nuclear	NULL
lysates	NULL
,	NULL
radiolabeling	NULL
of	NULL
oligonucleotide	NULL
probes	NULL
,	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
analysis	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Anti-NFIL3/E4BP4	NULL
rabbit	NULL
sera	NULL
were	NULL
prepared	NULL
from	NULL
animals	NULL
injected	NULL
with	NULL
recombinant	NULL
human	NULL
protein	NULL
,	NULL
and	NULL
1	NULL
pl	NULL
per	NULL
lane	NULL
was	NULL
used	NULL
in	NULL
antibody-perturbed	NULL
gel-shift	NULL
analyses	NULL
.	NULL

Immunoblot	NULL
Analysis	NULL
.	NULL

Cells	NULL
(	NULL
7.5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
lysed	NULL
in	NULL
RIPA	NULL
buffer	NULL
(	NULL
150	NULL
mM	NULL
NaCl/1.0	NULL
%	NULL
Nonidet	NULL
P-40/0.5	NULL
%	NULL
deoxy-cholate/0.1	NULL
%	NULL
SDS/50	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
8.0	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
protease	NULL
inhibitors	NULL
,	NULL
and	NULL
total	NULL
cellular	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS/PAGE	NULL
.	NULL

After	NULL
wet	NULL
electrotransfer	NULL
onto	NULL
nitrocellulose	NULL
membranes	NULL
,	NULL
immunoblotting	NULL
was	NULL
performed	NULL
with	NULL
anti-NFIL3/E4BP4	NULL
rabbit	NULL
serum	NULL
.	NULL

Blots	NULL
were	NULL
incubated	NULL
with	NULL
horse-radish-conjugated	NULL
anti-rabbit	NULL
Ig	NULL
secondary	NULL
antibodies	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
with	NULL
enhanced	NULL
chemilumines-cence	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Northern	NULL
Blot	NULL
Analysis	NULL
.	NULL

Twenty	NULL
micrograms	NULL
of	NULL
total	NULL
RNA	NULL
was	NULL
separated	NULL
by	NULL
electrophoresis	NULL
in	NULL
1	NULL
%	NULL
agarose	NULL
gels	NULL
containing	NULL
2.2	NULL
M	NULL
formaldehyde	NULL
,	NULL
transferred	NULL
to	NULL
nylon	NULL
membranes	NULL
,	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
following	NULL
hybridization	NULL
to	NULL
a	NULL
murine	NULL
Nfi	NULL
#	NULL
l3/E4bp4	NULL
,	NULL
GAPDH	NULL
(	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
)	NULL
or	NULL
rat	NULL
c-fos	NULL
P-labeled	NULL
cDNA	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
Any	NULL
one	NULL
of	NULL
several	NULL
mammalian	NULL
bZIP	NULL
proteins	NULL
could	NULL
serve	NULL
as	NULL
a	NULL
transcription	NULL
factor	NULL
that	NULL
transduces	NULL
survival	NULL
signals	NULL
from	NULL
the	NULL
IL-3	NULL
receptor	NULL
and	NULL
whose	NULL
function	NULL
is	NULL
replaced	NULL
by	NULL
the	NULL
E2A-HLF	NULL
oncoprotein	NULL
in	NULL
leukemic	NULL
pro-B	NULL
cells	NULL
.	NULL

As	NULL
a	NULL
first	NULL
step	NULL
in	NULL
our	NULL
search	NULL
for	NULL
such	NULL
a	NULL
growth-factor-regulated	NULL
anti-apoptotic	NULL
transcription	NULL
factor	NULL
,	NULL
we	NULL
employed	NULL
a	NULL
sensitive	NULL
antibody-perturbed	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
with	NULL
the	NULL
HLF	NULL
consensus	NULL
sequence	NULL
(	NULL
HLF-CS	NULL
)	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

Our	NULL
analysis	NULL
demonstrated	NULL
that	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
Nfil3/E4bp4	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
but	NULL
not	NULL
that	NULL
of	NULL
HIf	NULL
,	NULL
Dbp	NULL
,	NULL
or	NULL
Tef	NULL
(	NULL
the	NULL
mammalian	NULL
PAR	NULL
proteins	NULL
,	NULL
which	NULL
were	NULL
undetectable	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
is	NULL
regulated	NULL
by	NULL
IL-3	NULL
in	NULL
growth	NULL
factor-dependent	NULL
murine	NULL
pro-B	NULL
lymphocytes	NULL
[	NULL
Baf-3	NULL
(	NULL
5	NULL
)	NULL
or	NULL
FL5.12	NULL
(	NULL
21	NULL
)	NULL
]	NULL
.	NULL

Nfil3/E4bp4	NULL
binding	NULL
activity	NULL
was	NULL
rapidly	NULL
down-regulated	NULL
after	NULL
IL-3	NULL
deprivation	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
,	NULL
reappearing	NULL
within	NULL
2-3	NULL
hr	NULL
after	NULL
restoration	NULL
of	NULL
the	NULL
growth	NULL
factor	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
indicative	NULL
of	NULL
its	NULL
dependence	NULL
on	NULL
signals	NULL
transduced	NULL
through	NULL
the	NULL
IL-3	NULL
receptor	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
SP1	NULL
(	NULL
22	NULL
)	NULL
remained	NULL
unchanged	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
4	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Additional	NULL
controls	NULL
demonstrated	NULL
the	NULL
specificity	NULL
of	NULL
native	NULL
and	NULL
supershifted	NULL
Nfil3/EA4bp4-DNA	NULL
complexes	NULL
,	NULL
in	NULL
that	NULL
they	NULL
were	NULL
ablated	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
nonradiolabeled	NULL
HLF-CS	NULL
oligonucleotide	NULL
competitor	NULL
,	NULL
but	NULL
unaffected	NULL
by	NULL
an	NULL
oligonucleotide	NULL
with	NULL
altered	NULL
base	NULL
pairs	NULL
in	NULL
the	NULL
HLF	NULL
consensus	NULL
binding	NULL
sequence	NULL
(	NULL
HLF-M4	NULL
;	NULL
see	NULL
ref	NULL
.	NULL

12	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Levels	NULL
of	NULL
the	NULL
Nfil3/	NULL
EA4bp4	NULL
protein	NULL
paralleled	NULL
its	NULL
binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
,	NULL
suggesting	NULL
control	NULL
at	NULL
the	NULL
level	NULL
of	NULL
synthesis	NULL
of	NULL
a	NULL
relatively	NULL
short-lived	NULL
protein	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
effects	NULL
of	NULL
IL-3	NULL
on	NULL
Nfil3/E4bp4	NULL
mRNA	NULL
levels	NULL
,	NULL
we	NULL
isolated	NULL
the	NULL
mouse	NULL
cDNA	NULL
,	NULL
which	NULL
encodes	NULL
a	NULL
protein	NULL
highly	NULL
conserved	NULL
with	NULL
respect	NULL
to	NULL
human	NULL
E4BP4	NULL
(	NULL
100	NULL
%	NULL
identical	NULL
in	NULL
the	NULL
bZIP	NULL
domain	NULL
and	NULL
84.4	NULL
%	NULL
identical	NULL
overall	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
with	NULL
this	NULL
probe	NULL
demonstrated	NULL
that	NULL
Nfil3/E4bp4	NULL
mRNA	NULL
expression	NULL
depends	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
IL-3	NULL
.	NULL

A	NULL
marked	NULL
decline	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
mRNA	NULL
occurred	NULL
within	NULL
2	NULL
hr	NULL
of	NULL
IL-3	NULL
deprivation	NULL
,	NULL
with	NULL
maximal	NULL
levels	NULL
attained	NULL
1-2	NULL
hr	NULL
after	NULL
reintroduction	NULL
of	NULL
IL-3	NULL
into	NULL
the	NULL
medium	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
Nfil3/E4bp4	NULL
mRNA	NULL
was	NULL
delayed	NULL
with	NULL
respect	NULL
to	NULL
that	NULL
of	NULL
the	NULL
``	NULL
immediate-early	NULL
``	NULL
gene	NULL
c-fos	NULL
,	NULL
which	NULL
reached	NULL
maximal	NULL
levels	NULL
after	NULL
15	NULL
min	NULL
of	NULL
treatment	NULL
.	NULL

Moreover	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
c-fos	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
Nfil3/E4bp4	NULL
by	NULL
IL-3	NULL
was	NULL
blocked	NULL
by	NULL
cycloheximide	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
NfHl3/E4bp4	NULL
is	NULL
transcriptionally	NULL
regulated	NULL
as	NULL
a	NULL
``	NULL
delayed-early	NULL
``	NULL
IL-3-responsive	NULL
gene	NULL
that	NULL
is	NULL
dependent	NULL
upon	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
2611	NULL
A	NULL
Baf-3	NULL
-IL-3	NULL
+	NULL
IL-3	NULL
cells	NULL
,	NULL
ro-hr	NULL
o	NULL
2	NULL
4	NULL
8	NULL
12	NULL
min	NULL
0	NULL
'	NULL
15	NULL
30	NULL
60	NULL
120	NULL
EABP4D	NULL
S	NULL
>	NULL
'..	NULL
GaPpHDP	NULL
a	NULL
...	NULL
FL5.12	NULL
cells	NULL
Coury	NULL
E4BP4D	NULL
SS	NULL
>	NULL
[	NULL
~OUVDU	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
--	NULL
1°	NULL
2	NULL
3	NULL
4	NULL
5	NULL
B	NULL
+	NULL
IL-3	NULL
+	NULL
CHX	NULL
+	NULL
IL-3	NULL
and	NULL
CHX	NULL
min	NULL
0	NULL
15	NULL
30	NULL
60	NULL
120	NULL
180	NULL
15	NULL
30	NULL
60	NULL
120	NULL
180	NULL
15	NULL
30	NULL
60	NULL
120	NULL
180	NULL
EaBp4	NULL
©	NULL
#	NULL
GAPDH	NULL
n	NULL
R	NULL
102	NULL
3	NULL
40	NULL
50	NULL
60	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
w*	NULL
aab	NULL
tab	NULL
WP	NULL
HB	NULL
ao	NULL
wa	NULL
#	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Nfil3/EA4bp4	NULL
expression	NULL
is	NULL
regulated	NULL
by	NULL
IL-3	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
total	NULL
RNA	NULL
(	NULL
20	NULL
ug	NULL
per	NULL
lane	NULL
)	NULL
prepared	NULL
from	NULL
Baf-3	NULL
(	NULL
Upper	NULL
)	NULL
or	NULL
FL5.12	NULL
(	NULL
Lower	NULL
)	NULL
pro-B	NULL
lymphocytes	NULL
were	NULL
grown	NULL
in	NULL
IL-3	NULL
{	NULL
Jane	NULL
1	NULL
)	NULL
and	NULL
then	NULL
deprived	NULL
of	NULL
the	NULL
ligand	NULL
for	NULL
the	NULL
indicated	NULL
intervals	NULL
{	NULL
Janes	NULL
2-5	NULL
)	NULL
.	NULL

Cells	NULL
starved	NULL
of	NULL
ligand	NULL
for	NULL
8	NULL
hr	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
were	NULL
restimulated	NULL
with	NULL
10	NULL
ng/ml	NULL
of	NULL
murine	NULL
IL-3	NULL
and	NULL
incubated	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
{	NULL
Janes	NULL
8-11	NULL
)	NULL
.	NULL

Blots	NULL
were	NULL
hybridized	NULL
with	NULL
an	NULL
Nf	NULL
#	NULL
3/E4bp4	NULL
probe	NULL
and	NULL
stripped	NULL
and	NULL
rehybridized	NULL
with	NULL
the	NULL
GAPDH	NULL
control	NULL
probe	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Induction	NULL
of	NULL
NfH/3/E4bp4	NULL
by	NULL
IL-3	NULL
requires	NULL
protein	NULL
synthesis	NULL
.	NULL

Asynchronously	NULL
growing	NULL
FL5.12	NULL
cells	NULL
were	NULL
deprived	NULL
of	NULL
IL-3	NULL
for	NULL
16	NULL
hr	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
stimulated	NULL
with	NULL
either	NULL
IL-3	NULL
alone	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
(	NULL
lanes	NULL
2-6	NULL
)	NULL
,	NULL
or	NULL
with	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
,	NULL
20	NULL
ug/ml	NULL
)	NULL
alone	NULL
(	NULL
lanes	NULL
7-11	NULL
)	NULL
,	NULL
or	NULL
were	NULL
pretreated	NULL
with	NULL
CHX	NULL
for	NULL
15	NULL
min	NULL
and	NULL
incubated	NULL
in	NULL
both	NULL
IL-3	NULL
and	NULL
CHX	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
(	NULL
lanes	NULL
12-16	NULL
)	NULL
.	NULL

Northern	NULL
blots	NULL
were	NULL
sequentially	NULL
hybridized	NULL
with	NULL
probes	NULL
for	NULL
Nf	NULL
#	NULL
l3/E4bp4	NULL
,	NULL
c-fos	NULL
,	NULL
and	NULL
GAPDH	NULL
.	NULL

To	NULL
test	NULL
the	NULL
function	NULL
of	NULL
NFIL3/E4BP4	NULL
,	NULL
we	NULL
introduced	NULL
the	NULL
human	NULL
NFIL3/E4BP4	NULL
cDNA	NULL
into	NULL
FL5.12	NULL
cells	NULL
using	NULL
a	NULL
zinc-regulated	NULL
eukaryotic	NULL
expression	NULL
vector	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
IL-3	NULL
,	NULL
NFIL3/E4BP4	NULL
binding	NULL
activity	NULL
was	NULL
only	NULL
modestly	NULL
elevated	NULL
after	NULL
zinc	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
Upper	NULL
)	NULL
,	NULL
whereas	NULL
in	NULL
cells	NULL
deprived	NULL
of	NULL
IL-3	NULL
,	NULL
it	NULL
was	NULL
maintained	NULL
at	NULL
higher-than-normal	NULL
levels	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
zinc	NULL
,	NULL
despite	NULL
a	NULL
dramatic	NULL
decrease	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
metal	NULL
induction	NULL
.	NULL

In	NULL
a	NULL
kinetic	NULL
experiment	NULL
with	NULL
cells	NULL
2612	NULL
Medical	NULL
Sciences	NULL
:	NULL
Ikushima	NULL
et	NULL
al	NULL
.	NULL

A	NULL
FL5.12/E4BP4	NULL
clones	NULL
#	NULL
2	NULL
#	NULL
8	NULL
#	NULL
9	NULL
#	NULL
10	NULL
Zn	NULL
-	NULL
+0	NULL
0-0	NULL
&	NULL
-o	NULL
400-0	NULL
400	NULL
s	NULL
--	NULL
-	NULL
ik	NULL
,	NULL
*	NULL
»	NULL
*	NULL
w	NULL
UD	NULL
-	NULL
w	NULL
--	NULL
W	NULL
-	NULL
W	NULL
«	NULL
5459s	NULL
-IL-3	NULL
y	NULL
y	NULL
wil	NULL
.	NULL

ws	NULL
.	NULL

``	NULL
<	NULL
E4BP4	NULL
10	NULL
2	NULL
O3	NULL
4050	NULL
060	NULL
7	NULL
oB	NULL
-Zn	NULL
+	NULL
Zn	NULL
B	NULL
``	NULL
-IL-3	NULL
``	NULL
-IL-3	NULL
|	NULL
hr	NULL
0	NULL
4	NULL
8	NULL
12	NULL
24	NULL
0	NULL
4	NULL
8	NULL
12	NULL
24	NULL
Empty	NULL
r	NULL
--	NULL
A	NULL
--	NULL
’	NULL
-	NULL
‘	NULL
--	NULL
F	NULL
``	NULL
a	NULL
f	NULL
FL5.12E4BP4	NULL
cione	NULL
#	NULL
9	NULL
-	NULL
WP	NULL
W	NULL
#	NULL
Wa	NULL
w	NULL
.	NULL

*	NULL
.	NULL

<	NULL
E4BP4	NULL
50060	NULL
7	NULL
s	NULL
9	NULL
40	NULL
10	NULL
20	NULL
3	NULL
4	NULL
<	NULL
E4BP4	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Transfected	NULL
pro-B	NULL
cell	NULL
clones	NULL
conditionally	NULL
overexpressing	NULL
NFIL3/E4BPA4	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Antibody-perturbed	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
of	NULL
FLS5.12	NULL
clones	NULL
expressing	NULL
NFIL3/E4BP4	NULL
from	NULL
the	NULL
zinc-regulated	NULL
pMT-CB6+	NULL
expression	NULL
plasmid	NULL
.	NULL

Solid	NULL
arrowheads	NULL
indicate	NULL
NFIL3/E4BP4-DNA	NULL
complexes	NULL
from	NULL
each	NULL
of	NULL
four	NULL
independent	NULL
clones	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
even	NULL
lanes	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
odd	NULL
lanes	NULL
)	NULL
of	NULL
zinc	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-3	NULL
for	NULL
24	NULL
hr	NULL
(	NULL
+IL-3	NULL
,	NULL
Upper	NULL
)	NULL
or	NULL
16	NULL
hr	NULL
after	NULL
its	NULL
removal	NULL
(	NULL
-IL-3	NULL
,	NULL
Lower	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
A	NULL
time	NULL
course	NULL
of	NULL
NFIL3/E4BP4	NULL
binding	NULL
activity	NULL
in	NULL
FL5.12	NULL
cells	NULL
bearing	NULL
the	NULL
empty	NULL
zinc-regulated	NULL
vector	NULL
(	NULL
Upper	NULL
)	NULL
or	NULL
the	NULL
vector	NULL
containing	NULL
NFIL3/E4BP4	NULL
(	NULL
clone	NULL
9	NULL
;	NULL
Lower	NULL
)	NULL
.	NULL

The	NULL
mobility	NULL
assay	NULL
was	NULL
performed	NULL
with	NULL
extracts	NULL
from	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
{	NULL
Janes	NULL
6-10	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
lanes	NULL
1-5	NULL
)	NULL
of	NULL
zinc	NULL
,	NULL
and	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-3	NULL
{	NULL
Janes	NULL
1	NULL
and	NULL
6	NULL
)	NULL
,	NULL
or	NULL
at	NULL
the	NULL
indicated	NULL
intervals	NULL
after	NULL
its	NULL
removal	NULL
.	NULL

Solid	NULL
arrowheads	NULL
indicate	NULL
NFIL3/E4BP4-DNA	NULL
complexes	NULL
that	NULL
supershifted	NULL
with	NULL
E4BP4	NULL
antiserum	NULL
.	NULL

from	NULL
clone	NULL
9	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
,	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NFIL3/	NULL
EABPA4	NULL
remained	NULL
elevated	NULL
in	NULL
IL-3-deprived	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
zinc	NULL
(	NULL
Lower	NULL
Right	NULL
)	NULL
,	NULL
but	NULL
it	NULL
declined	NULL
rapidly	NULL
when	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
medium	NULL
lacking	NULL
both	NULL
zinc	NULL
and	NULL
IL-3	NULL
(	NULL
Lower	NULL
Left	NULL
)	NULL
.	NULL

The	NULL
functional	NULL
significance	NULL
of	NULL
NFIL3/E4BPA4	NULL
expression	NULL
was	NULL
demonstrated	NULL
in	NULL
four	NULL
clones	NULL
,	NULL
each	NULL
of	NULL
which	NULL
showed	NULL
prolonged	NULL
survival	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
zinc	NULL
after	NULL
IL-3	NULL
deprivation	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
zinc	NULL
,	NULL
the	NULL
cells	NULL
underwent	NULL
rapid	NULL
apoptosis	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
,	NULL
as	NULL
did	NULL
control	NULL
cells	NULL
regardless	NULL
of	NULL
zinc	NULL
concentration	NULL
.	NULL

While	NULL
dramatic	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
enforced	NULL
NFIL3/E4BP4	NULL
expression	NULL
on	NULL
survival	NULL
were	NULL
less	NULL
potent	NULL
than	NULL
those	NULL
previously	NULL
observed	NULL
for	NULL
E2A-HLF	NULL
when	NULL
it	NULL
was	NULL
expressed	NULL
in	NULL
Baf-3	NULL
cells	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
same	NULL
zinc-inducible	NULL
vector	NULL
(	NULL
10	NULL
)	NULL
.	NULL

This	NULL
appeared	NULL
to	NULL
be	NULL
due	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
,	NULL
after	NULL
IL-3	NULL
had	NULL
been	NULL
removed	NULL
for	NULL
48	NULL
hr	NULL
,	NULL
NFIL3/E4BP4	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
zinc-treated	NULL
transfectants	NULL
fell	NULL
below	NULL
levels	NULL
detected	NULL
in	NULL
cells	NULL
growing	NULL
in	NULL
medium	NULL
containing	NULL
IL-3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
needed	NULL
to	NULL
determine	NULL
whether	NULL
protein	NULL
levels	NULL
are	NULL
affected	NULL
,	NULL
or	NULL
whether	NULL
additional	NULL
posttranslational	NULL
modifica-tions	NULL
,	NULL
such	NULL
as	NULL
phosphorylation	NULL
(	NULL
23	NULL
)	NULL
,	NULL
are	NULL
mediated	NULL
in	NULL
response	NULL
to	NULL
IL-3	NULL
and	NULL
required	NULL
for	NULL
full	NULL
activity	NULL
of	NULL
NFIL3/E4BP4	NULL
as	NULL
a	NULL
mediator	NULL
of	NULL
DNA	NULL
binding	NULL
and	NULL
cell	NULL
survival	NULL
.	NULL

Although	NULL
NFIL3/EA4BP4	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
trans-activate	NULL
the	NULL
IL-3	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
20	NULL
)	NULL
,	NULL
its	NULL
effects	NULL
on	NULL
the	NULL
survival	NULL
of	NULL
FL5.12	NULL
pro-B	NULL
cells	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
mediated	NULL
through	NULL
an	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
J	NULL
-J-	NULL
#	NULL
2	NULL
-O-	NULL
#	NULL
8	NULL
-/-	NULL
#	NULL
9	NULL
=O-	NULL
#	NULL
10	NULL
-	NULL
@	NULL
-	NULL
Empty	NULL
vector	NULL
Viable	NULL
cell	NULL
number	NULL
(	NULL
x	NULL
10°/ml	NULL
)	NULL
B	NULL
-o-	NULL
#	NULL
2	NULL
-G-	NULL
#	NULL
8	NULL
-i-	NULL
#	NULL
9	NULL
~	NULL
-o-	NULL
#	NULL
10	NULL
mg	NULL
-	NULL
@	NULL
-	NULL
Empty	NULL
vector	NULL
o	NULL
r	NULL
x	NULL
put	NULL
G	NULL
a	NULL
[	NULL
3	NULL
3	NULL
C	NULL
c	NULL
6	NULL
&	NULL
a	NULL
£	NULL
>	NULL
Days	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

-	NULL
NFIL3/E4BP4	NULL
suppresses	NULL
apoptosis	NULL
of	NULL
IL-3-deprived	NULL
murine	NULL
pro-B	NULL
cells	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Numbers	NULL
of	NULL
viable	NULL
cells	NULL
at	NULL
serial	NULL
times	NULL
after	NULL
IL-3	NULL
withdrawal	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
zinc	NULL
for	NULL
FL5.12	NULL
clones	NULL
transfected	NULL
with	NULL
zinc-regulatable	NULL
NFIL3/E4BP4	NULL
plasmid	NULL
or	NULL
the	NULL
empty	NULL
vector	NULL
(	NULL
means	NULL
of	NULL
triplicate	NULL
counts	NULL
,	NULL
with	NULL
bars	NULL
showing	NULL
standard	NULL
deviations	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Viable	NULL
cell	NULL
counts	NULL
of	NULL
the	NULL
same	NULL
clones	NULL
after	NULL
IL-3	NULL
withdrawal	NULL
and	NULL
culture	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
zinc	NULL
to	NULL
induce	NULL
NFIL3/E4BP4	NULL
expression	NULL
.	NULL

Representative	NULL
data	NULL
from	NULL
seven	NULL
independent	NULL
experiments	NULL
are	NULL
presented	NULL
;	NULL
comparable	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
nine	NULL
independently	NULL
derived	NULL
pools	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
NFIL3/E4BP4	NULL
plasmid	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

autocrine	NULL
mechanism	NULL
,	NULL
as	NULL
IL-3	NULL
mRNA	NULL
was	NULL
not	NULL
detectable	NULL
in	NULL
clones	NULL
overexpressing	NULL
NFIL3/E4BP4	NULL
,	NULL
and	NULL
conditioned	NULL
media	NULL
from	NULL
these	NULL
cells	NULL
did	NULL
not	NULL
promote	NULL
the	NULL
growth	NULL
or	NULL
survival	NULL
of	NULL
wild-type	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
murine	NULL
lympho-blasts	NULL
with	NULL
enforced	NULL
expression	NULL
of	NULL
NFIL3/E4BP4	NULL
accumulated	NULL
in	NULL
Go/G1	NULL
phase	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-3	NULL
,	NULL
and	NULL
the	NULL
administration	NULL
of	NULL
zinc	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-3	NULL
did	NULL
not	NULL
effect	NULL
cell	NULL
growth	NULL
rate	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
NFIL3/EABP4	NULL
promotes	NULL
survival	NULL
,	NULL
but	NULL
does	NULL
not	NULL
transduce	NULL
proliferative	NULL
signals	NULL
mediated	NULL
by	NULL
growth	NULL
factor-induced	NULL
activation	NULL
of	NULL
the	NULL
IL-3	NULL
receptor	NULL
.	NULL

No	NULL
significant	NULL
changes	NULL
were	NULL
observed	NULL
in	NULL
levels	NULL
of	NULL
the	NULL
Bel-2	NULL
,	NULL
Bcl-x	NULL
;	NULL
Bax	NULL
,	NULL
and	NULL
Bad	NULL
proteins	NULL
(	NULL
reviewed	NULL
in	NULL
refs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
in	NULL
cells	NULL
overexpressing	NULL
NFIL3/E4BPA4	NULL
(	NULL
negative	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
on	NULL
survival	NULL
are	NULL
not	NULL
mediated	NULL
through	NULL
induction	NULL
of	NULL
these	NULL
regulators	NULL
of	NULL
apoptotic	NULL
signaling	NULL
.	NULL

However	NULL
,	NULL
we	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
Bcel-2	NULL
family	NULL
members	NULL
is	NULL
affected	NULL
by	NULL
posttranslational	NULL
modifications	NULL
or	NULL
by	NULL
alterations	NULL
in	NULL
complexes	NULL
of	NULL
these	NULL
proteins	NULL
.	NULL

For	NULL
example	NULL
,	NULL
in	NULL
one	NULL
recent	NULL
study	NULL
,	NULL
Zha	NULL
Medical	NULL
Sciences	NULL
:	NULL
Ikushima	NULL
et	NULL
al	NULL
.	NULL

..-	NULL
trans	NULL
~activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
2613	NULL
Survival	NULL
i	NULL
Target	NULL
Gene	NULL
Apoptosis	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

-	NULL
Model	NULL
of	NULL
NFIL3/E4BP4	NULL
function	NULL
in	NULL
cell	NULL
survival	NULL
pathways	NULL
and	NULL
a	NULL
proposed	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
the	NULL
EZ2A-HLF	NULL
oncoprotein	NULL
in	NULL
the	NULL
transformation	NULL
of	NULL
pro-B	NULL
lymphocytes	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
NFIL3/E4BP4	NULL
gene	NULL
is	NULL
tightly	NULL
regulated	NULL
by	NULL
IL-3	NULL
through	NULL
an	NULL
undefined	NULL
signal	NULL
transduction	NULL
pathway	NULL
emanating	NULL
from	NULL
the	NULL
ligand-activated	NULL
IL-3	NULL
receptor	NULL
.	NULL

The	NULL
NFIL3/E4BP4	NULL
transcription	NULL
factor	NULL
binds	NULL
to	NULL
a	NULL
consensus	NULL
sequence	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
downstream	NULL
target	NULL
genes	NULL
,	NULL
leading	NULL
to	NULL
trans-activation	NULL
of	NULL
critical	NULL
survival	NULL
signals	NULL
.	NULL

Because	NULL
HLF	NULL
and	NULL
NFIL3/E4BP4	NULL
can	NULL
recognize	NULL
the	NULL
same	NULL
DNA	NULL
binding	NULL
site	NULL
,	NULL
the	NULL
constitutively	NULL
expressed	NULL
EZA-HLF	NULL
oncoprotein	NULL
can	NULL
replace	NULL
the	NULL
function	NULL
of	NULL
the	NULL
normal	NULL
IL-3-regulated	NULL
transcription	NULL
factor	NULL
,	NULL
accounting	NULL
for	NULL
its	NULL
anti-apoptotic	NULL
role	NULL
in	NULL
leukemogenesis	NULL
.	NULL

An	NULL
additional	NULL
prediction	NULL
of	NULL
the	NULL
model	NULL
is	NULL
that	NULL
the	NULL
consensus	NULL
binding	NULL
site	NULL
(	NULL
TTACGTAA	NULL
)	NULL
could	NULL
serve	NULL
as	NULL
a	NULL
versatile	NULL
regulatory	NULL
switch	NULL
,	NULL
allowing	NULL
other	NULL
,	NULL
still-to-be-identified	NULL
mammalian	NULL
CES-2	NULL
homologues	NULL
to	NULL
contribute	NULL
to	NULL
programmed	NULL
cell	NULL
death	NULL
by	NULL
acting	NULL
as	NULL
trans-repressors	NULL
of	NULL
this	NULL
pathway	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
24	NULL
)	NULL
found	NULL
that	NULL
phosphorylation	NULL
of	NULL
Bad	NULL
on	NULL
serine	NULL
residues	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-3	NULL
resulted	NULL
in	NULL
its	NULL
binding	NULL
to	NULL
the	NULL
14-3-3	NULL
protein	NULL
rather	NULL
than	NULL
plus	NULL
blocking	NULL
the	NULL
pro-apoptotic	NULL
function	NULL
of	NULL
Bad	NULL
.	NULL

Although	NULL
the	NULL
precise	NULL
role	NULL
of	NULL
IL-3	NULL
in	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
B	NULL
lymphopoiesis	NULL
is	NULL
unknown	NULL
,	NULL
the	NULL
growth	NULL
factor	NULL
was	NULL
required	NULL
to	NULL
isolate	NULL
clonal	NULL
pro-B	NULL
and	NULL
pre-B	NULL
cell	NULL
lines	NULL
(	NULL
5	NULL
,	NULL
21	NULL
,	NULL
25	NULL
,	NULL
26	NULL
)	NULL
,	NULL
and	NULL
the	NULL
IL-3	NULL
gene	NULL
is	NULL
activated	NULL
in	NULL
some	NULL
cases	NULL
of	NULL
human	NULL
acute	NULL
pro-B	NULL
cell	NULL
leukemia	NULL
associated	NULL
with	NULL
the	NULL
t	NULL
(	NULL
5	NULL
;	NULL
14	NULL
)	NULL
chromosomal	NULL
translocation	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

The	NULL
apparent	NULL
leukemogenic	NULL
effects	NULL
of	NULL
IL-3	NULL
activation	NULL
in	NULL
man	NULL
strongly	NULL
suggest	NULL
that	NULL
the	NULL
cytokine	NULL
mediates	NULL
cell	NULL
growth	NULL
and	NULL
survival	NULL
in	NULL
at	NULL
least	NULL
a	NULL
subset	NULL
of	NULL
early	NULL
B	NULL
cell	NULL
progenitors	NULL
.	NULL

Here	NULL
we	NULL
provide	NULL
insight	NULL
into	NULL
the	NULL
transcriptional	NULL
mechanism	NULL
through	NULL
which	NULL
IL-3	NULL
influences	NULL
progenitor	NULL
cell	NULL
survival	NULL
during	NULL
B	NULL
lymphopoiesis	NULL
,	NULL
demonstrating	NULL
that	NULL
NFIL3/	NULL
EABPA4	NULL
is	NULL
positively	NULL
regulated	NULL
by	NULL
IL-3	NULL
and	NULL
functions	NULL
downstream	NULL
of	NULL
the	NULL
IL-3	NULL
receptor	NULL
to	NULL
block	NULL
the	NULL
programmed	NULL
cell	NULL
death	NULL
that	NULL
results	NULL
from	NULL
growth	NULL
factor	NULL
deprivation	NULL
.	NULL

The	NULL
oncogenic	NULL
transcription	NULL
factor	NULL
EZ2A-HLF	NULL
,	NULL
which	NULL
binds	NULL
the	NULL
same	NULL
DNA	NULL
consensus	NULL
sequence	NULL
as	NULL
NFIL3/EABP4	NULL
,	NULL
also	NULL
protects	NULL
pro-B	NULL
cells	NULL
from	NULL
programmed	NULL
cell	NULL
death	NULL
(	NULL
10	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
both	NULL
act	NULL
through	NULL
a	NULL
common	NULL
downstream	NULL
signaling	NULL
pathway	NULL
.	NULL

Functional	NULL
studies	NULL
indicate	NULL
a	NULL
positive	NULL
regulatory	NULL
role	NULL
for	NULL
E2A-HLF	NULL
in	NULL
gene	NULL
expression	NULL
,	NULL
mediated	NULL
through	NULL
two	NULL
separate	NULL
domains	NULL
(	NULL
AD1	NULL
and	NULL
AD2	NULL
)	NULL
in	NULL
the	NULL
E2A	NULL
fusion	NULL
element	NULL
that	NULL
act	NULL
as	NULL
potent	NULL
trans-activators	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
several	NULL
contexts	NULL
(	NULL
12	NULL
,	NULL
13	NULL
,	NULL
29-31	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
NFIL3/E4BP4	NULL
can	NULL
function	NULL
as	NULL
either	NULL
a	NULL
trans-repressor	NULL
or	NULL
trans-activator	NULL
of	NULL
transcription	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
and	NULL
promoter	NULL
contexts	NULL
(	NULL
18-20	NULL
)	NULL
.	NULL

The	NULL
C.	NULL
elegans	NULL
cell	NULL
death	NULL
specification	NULL
protein	NULL
CES-2	NULL
is	NULL
highly	NULL
related	NULL
to	NULL
HLF	NULL
and	NULL
NFIL3/E4BP4	NULL
in	NULL
its	NULL
bZIP	NULL
domain	NULL
,	NULL
and	NULL
it	NULL
binds	NULL
to	NULL
the	NULL
same	NULL
DNA	NULL
consensus	NULL
sequence	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Genetic	NULL
evidence	NULL
suggests	NULL
that	NULL
the	NULL
CES-2	NULL
protein	NULL
acts	NULL
as	NULL
a	NULL
transcriptional	NULL
repressor	NULL
to	NULL
induce	NULL
programmed	NULL
cell	NULL
death	NULL
in	NULL
the	NULL
sister	NULL
cells	NULL
of	NULL
serotoninergic	NULL
neurosecretory	NULL
motor	NULL
neurons	NULL
during	NULL
C.	NULL
elegans	NULL
embryogenesis	NULL
(	NULL
11	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
the	NULL
consensus	NULL
binding	NULL
sequence	NULL
recognized	NULL
by	NULL
HLF	NULL
,	NULL
NFIL3/E4BP4	NULL
,	NULL
and	NULL
CES-2	NULL
may	NULL
serve	NULL
as	NULL
a	NULL
versatile	NULL
regulatory	NULL
switch	NULL
in	NULL
the	NULL
promoter	NULL
regions	NULL
of	NULL
target	NULL
genes	NULL
,	NULL
either	NULL
inducing	NULL
(	NULL
CES-2	NULL
)	NULL
or	NULL
suppressing	NULL
(	NULL
NFIL3/E4BPA4	NULL
,	NULL
E2A-HLF	NULL
)	NULL
apoptosis	NULL
,	NULL
depending	NULL
on	NULL
site	NULL
occupancy	NULL
.	NULL

We	NULL
therefore	NULL
propose	NULL
that	NULL
E2A-HLF	NULL
,	NULL
due	NULL
to	NULL
its	NULL
constitutive	NULL
expression	NULL
in	NULL
pro-B	NULL
cells	NULL
carrying	NULL
the	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
,	NULL
replaces	NULL
NFIL3/E4BP4	NULL
in	NULL
a	NULL
novel	NULL
IL-3-dependent	NULL
survival	NULL
pathway	NULL
,	NULL
trans-activating	NULL
a	NULL
target	NULL
gene	NULL
or	NULL
genes	NULL
whose	NULL
expression	NULL
is	NULL
critical	NULL
for	NULL
downstream	NULL
anti-apoptotic	NULL
signaling	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

As	NULL
these	NULL
lymphoid	NULL
progenitors	NULL
accumulate	NULL
,	NULL
they	NULL
likely	NULL
acquire	NULL
additional	NULL
mutations	NULL
of	NULL
growth	NULL
regulatory	NULL
genes	NULL
needed	NULL
to	NULL
produce	NULL
overt	NULL
human	NULL
B-lineage	NULL
acute	NULL
leukemia	NULL
.	NULL

We	NULL
thank	NULL
R.	NULL
Ashmun	NULL
for	NULL
assistance	NULL
with	NULL
flow	NULL
cytometric	NULL
analysis	NULL
;	NULL
B.	NULL
Jones	NULL
,	NULL
H.	NULL
Yang	NULL
,	NULL
and	NULL
K.	NULL
Dittmer	NULL
for	NULL
technical	NULL
assistance	NULL
;	NULL
F.	NULL
Rauscher	NULL
III	NULL
for	NULL
providing	NULL
the	NULL
pMT-CB6+	NULL
expression	NULL
vector	NULL
;	NULL
J.	NULL
Gilbert	NULL
for	NULL
scientific	NULL
editing	NULL
;	NULL
and	NULL
T.	NULL
Curran	NULL
and	NULL
C.	NULL
Sherr	NULL
for	NULL
comments	NULL
on	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
research	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
(	NULL
CA	NULL
59571	NULL
,	NULL
CA	NULL
20180	NULL
,	NULL
and	NULL
Cancer	NULL
Center	NULL
Core	NULL
CA	NULL
21765	NULL
)	NULL
and	NULL
the	NULL
National	NULL
Institute	NULL
of	NULL
Diabetes	NULL
and	NULL
Digestive	NULL
and	NULL
Kidney	NULL
Diseases	NULL
(	NULL
DK	NULL
44158	NULL
and	NULL
DK	NULL
43025	NULL
)	NULL
,	NULL
and	NULL
by	NULL
the	NULL
American	NULL
Lebanese	NULL
Syrian	NULL
Associated	NULL
Charities	NULL
,	NULL
St.	NULL
Jude	NULL
Children	NULL
's	NULL
Research	NULL
Hospital	NULL
.	NULL

Thompson	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Science	NULL
267	NULL
,	NULL
1456-1462	NULL
.	NULL

Yang	NULL
,	NULL
E.	NULL
&	NULL
Korsmeyer	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Blood	NULL
88	NULL
,	NULL
386-401	NULL
.	NULL

Strasser	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

7	NULL
,	NULL
228-234	NULL
.	NULL

Schrader	NULL
,	NULL
J.	NULL
W.	NULL
(	NULL
1986	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

4	NULL
,	NULL
205-230	NULL
.	NULL

Palacios	NULL
,	NULL
R.	NULL
,	NULL
Henson	NULL
,	NULL
G.	NULL
,	NULL
Steinmetz	NULL
,	NULL
M.	NULL
&	NULL
McKearn	NULL
,	NULL
J.	NULL
P.	NULL
(	NULL
1984	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
309	NULL
,	NULL
126-131	NULL
.	NULL

6	NULL
.	NULL

Williams	NULL
,	NULL
G.	NULL
T.	NULL
,	NULL
Smith	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Spooncer	NULL
,	NULL
E.	NULL
,	NULL
Dexter	NULL
,	NULL
T.	NULL
M.	NULL
&	NULL
Taylor	NULL
,	NULL
D.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
343	NULL
,	NULL
76-79	NULL
.	NULL

7	NULL
.	NULL

Rodriguez-Tarduchy	NULL
,	NULL
G.	NULL
,	NULL
Collins	NULL
,	NULL
M.	NULL
&	NULL
Lopez-Rivas	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

9	NULL
,	NULL
2997-3002	NULL
.	NULL

8	NULL
.	NULL

-	NULL
Inaba	NULL
,	NULL
T.	NULL
,	NULL
Roberts	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Shapiro	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
Jolly	NULL
,	NULL
K.	NULL
W.	NULL
,	NULL
Raimondi	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Smith	NULL
,	NULL
S.	NULL
D.	NULL
&	NULL
Look	NULL
,	NULL
A.	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
257	NULL
,	NULL
531-534	NULL
.	NULL

9	NULL
.	NULL

Hunger	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
Ohyashiki	NULL
,	NULL
K.	NULL
,	NULL
Toyama	NULL
,	NULL
K.	NULL
&	NULL
Cleary	NULL
,	NULL
M.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
1608-1620.	NULL
m	NULL
p	NULL
w	NULL
op-	NULL
2614	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

Medical	NULL
Sciences	NULL
:	NULL
Ikushima	NULL
et	NULL
al	NULL
.	NULL

Inaba	NULL
,	NULL
T.	NULL
,	NULL
Inukai	NULL
,	NULL
T.	NULL
,	NULL
Yoshihara	NULL
,	NULL
T.	NULL
,	NULL
Seyschab	NULL
,	NULL
H.	NULL
,	NULL
Ashmun	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Canman	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
Laken	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Kastan	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

&	NULL
Look	NULL
,	NULL
A.	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
382	NULL
,	NULL
541-544	NULL
.	NULL

Metzstein	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Hengartner	NULL
,	NULL
M.	NULL
O.	NULL
,	NULL
Tsung	NULL
,	NULL
N.	NULL
,	NULL
Ellis	NULL
,	NULL
R.	NULL
E.	NULL
&	NULL
Horvitz	NULL
,	NULL
H.	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
382	NULL
,	NULL
545-547	NULL
.	NULL

Inaba	NULL
,	NULL
T.	NULL
,	NULL
Shapiro	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
Funabiki	NULL
,	NULL
T.	NULL
,	NULL
Sinclair	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
Jones	NULL
,	NULL
B.	NULL
G.	NULL
,	NULL
Ashmun	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

&	NULL
Look	NULL
,	NULL
A.	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
3403-3413	NULL
.	NULL

Hunger	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
Brown	NULL
,	NULL
R.	NULL
&	NULL
Cleary	NULL
,	NULL
M.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
5986-5996	NULL
.	NULL

Falvey	NULL
,	NULL
E.	NULL
,	NULL
Fleury-Olela	NULL
,	NULL
F.	NULL
&	NULL
Schibler	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
4307-4317	NULL
.	NULL

Mueller	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
Maire	NULL
,	NULL
P.	NULL
&	NULL
Schibler	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
279-291	NULL
.	NULL

Fonjallaz	NULL
,	NULL
P.	NULL
,	NULL
Ossipow	NULL
,	NULL
V.	NULL
,	NULL
Wanner	NULL
,	NULL
G.	NULL
&	NULL
Schibler	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

351-356	NULL
.	NULL

Drolet	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Scully	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Simmons	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Wegner	NULL
,	NULL
M.	NULL
,	NULL
Chu	NULL
,	NULL
K.	NULL
T.	NULL
,	NULL
Swanson	NULL
,	NULL
L.	NULL
W.	NULL
&	NULL
Rosenfeld	NULL
,	NULL
M.	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
1739-1753	NULL
.	NULL

Cowell	NULL
,	NULL
I.	NULL
G.	NULL
,	NULL
Skinner	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Hurst	NULL
,	NULL
H.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
3070-3077	NULL
.	NULL

Cowell	NULL
,	NULL
I.	NULL
G.	NULL
&	NULL
Hurst	NULL
,	NULL
H.	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22	NULL
,	NULL
59-65	NULL
.	NULL

Zhang	NULL
,	NULL
W.	NULL
,	NULL
Zhang	NULL
,	NULL
J.	NULL
,	NULL
Kornuc	NULL
,	NULL
M.	NULL
,	NULL
Kwan	NULL
,	NULL
K.	NULL
,	NULL
Frank	NULL
,	NULL
R.	NULL
&	NULL
Nimer	NULL
,	NULL
S.	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
6055-6063	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
McKearn	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
McCubrey	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Fagg	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82	NULL
,	NULL
7414-7418	NULL
.	NULL

Courey	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

&	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
55	NULL
,	NULL
887-898	NULL
.	NULL

Chen	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Lewis	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Chandra	NULL
,	NULL
G.	NULL
,	NULL
Cogswell	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Stinnett	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
Kadwell	NULL
,	NULL
S.	NULL
H.	NULL
&	NULL
Gray	NULL
,	NULL
J.	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1264	NULL
,	NULL
388-396	NULL
.	NULL

Zha	NULL
,	NULL
J.	NULL
,	NULL
Harada	NULL
,	NULL
H.	NULL
,	NULL
Yang	NULL
,	NULL
E.	NULL
,	NULL
Jockel	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Korsmeyer	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Cell	NULL
87	NULL
,	NULL
619-628	NULL
.	NULL

Rennick	NULL
,	NULL
D.	NULL
,	NULL
Jackson	NULL
,	NULL
J.	NULL
,	NULL
Moulds	NULL
,	NULL
C.	NULL
,	NULL
Lee	NULL
,	NULL
F.	NULL
&	NULL
Yang	NULL
,	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

142	NULL
,	NULL
161-166	NULL
.	NULL

Palacios	NULL
,	NULL
R.	NULL
&	NULL
Steinmetz	NULL
,	NULL
M.	NULL
(	NULL
1985	NULL
)	NULL
Cell	NULL
41	NULL
,	NULL
727-734	NULL
.	NULL

Grimaldi	NULL
,	NULL
J.	NULL
C.	NULL
&	NULL
Meeker	NULL
,	NULL
T.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Blood	NULL
73	NULL
,	NULL
2081-2085	NULL
.	NULL

Meeker	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
Hardy	NULL
,	NULL
D.	NULL
,	NULL
Willman	NULL
,	NULL
C.	NULL
,	NULL
Hogan	NULL
,	NULL
T.	NULL
&	NULL
Abrams	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Blood	NULL
76	NULL
,	NULL
285-289	NULL
.	NULL

Henthorn	NULL
,	NULL
P.	NULL
,	NULL
Kiledjian	NULL
,	NULL
M.	NULL
&	NULL
Kadesch	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
247	NULL
,	NULL
467-470	NULL
.	NULL

Quong	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
Massari	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Zwart	NULL
,	NULL
R.	NULL
&	NULL
Murre	NULL
,	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
792-800	NULL
.	NULL

Aronheim	NULL
,	NULL
A.	NULL
,	NULL
Shiran	NULL
,	NULL
R.	NULL
,	NULL
Rosen	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Walker	NULL
,	NULL
M.	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
8063-8067	NULL
.	NULL

Ellis	NULL
,	NULL
R.	NULL
E.	NULL
&	NULL
Horvitz	NULL
,	NULL
H.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Development	NULL
(	NULL
Cambridge	NULL
,	NULL
U.K.	NULL
)	NULL
112	NULL
,	NULL
591-603	NULL
.	NULL

